Axogen Inc
Research Axogen Inc (AXGN) on Bullrun: market cap USD 2.68B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAXGN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 2.68B
- Financial periodQ2 2026
- RevenueUSD 69.73M
- Net income-USD 1.52M
- Free cash flowUSD 5.47M
- Gross margin72.7%
Valuation Snapshot
latest market cap is USD 2.68B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 225.21M | -USD 15.70M | -USD 2.93M | 74.3% | -0.34 | USD 35.55M | USD 48.39M | USD 128.85M |
| FY2024 | USD 187.34M | -USD 9.96M | USD 1.43M | 75.8% | -0.23 | USD 27.55M | USD 47.50M | USD 103.91M |
| FY2023 | USD 159.01M | -USD 21.72M | -USD 19.59M | 76.6% | -0.51 | USD 31.02M | USD 46.60M | USD 95.67M |
| FY2022 | USD 138.58M | -USD 28.95M | -USD 36.14M | 78.5% | -0.69 | USD 15.28M | USD 45.71M | USD 101.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.68B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.54B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 727.57M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 293.99M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 422.02M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 391.08M | n/a | n/a | n/a |
About Axogen Inc
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Axogen Inc's market cap?
Axogen Inc's market capitalization is USD 2.68B.
What does Axogen Inc do?
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps.